1. Naringin Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension Through Endothelial-To-Mesenchymal Transition Inhibition
   Yonghui Wu et al, 2021, Frontiers in Pharmacology CrossRef
2. Trapidil determines the fate of RHF rats through inhibition of ER stress
   Yilin Wang et al, 2020, Archives of Pharmacal Research CrossRef
3. SOX17 Loss-of-Function Mutation Underlying Familial Pulmonary Arterial Hypertension
   Tian-Ming Wang et al, 2021, International Heart Journal CrossRef
4. EndMT: Potential Target of H2S against Atherosclerosis
   Hui-Ting Liu et al, 2021, Current Medicinal Chemistry CrossRef
5. Modulation of EndMT by Hydrogen Sulfide in the Prevention of Cardiovascular Fibrosis
   Lara Testai et al, 2021, Antioxidants CrossRef
6. Hydrogen Sulfide Metabolism and Pulmonary Hypertension
   Lukas Roubenne et al, 2021, Cells CrossRef
7. Endothelial to Mesenchymal Transition in Pulmonary Vascular Diseases
   Eunsik Yun et al, 2020, Biomedicines CrossRef
8. Application of vascular endothelial cells in stem cell medicine
   Qing-Qing Liang et al, 2021, World Journal of Clinical Cases CrossRef
9. Implications of Hydrogen Sulfide in Development of Pulmonary Hypertension
   Yan Sun et al, 2022, Biomolecules CrossRef
10. Genetic Delivery and Gene Therapy in Pulmonary Hypertension
    Nabham Rai et al, 2021, International Journal of Molecular Sciences CrossRef